Scribe Therapeutics Inc. (SCTX) free cash flow

Free cash flow · fiscal 2025
-$46.48M

Only 2 fiscal years of free cash flow are on record here for Scribe Therapeutics Inc. (SCTX); a history needs at least 3. Figures as of 18 Nov 2026, 12:14 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$46.48M
Fiscal years on record
22024–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Not enough data

A history of free cash flow needs at least 3 fiscal years; 2 are on record here for Scribe Therapeutics Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.

Scribe Therapeutics Inc. free cash flow, year by year

Scribe Therapeutics Inc. (SCTX) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$46.48M—
2024-$46.58M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on SCTX

Scribe Therapeutics Inc., figure by figure

Scribe Therapeutics Inc. (SCTX) overview: price, valuation and scorecard

Scribe Therapeutics Inc. free cash flow: questions and answers

How is Scribe Therapeutics Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Scribe Therapeutics Inc. it is on record here for 2 fiscal years, 2024 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Scribe Therapeutics Inc. (SCTX) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/SCTX/free-cash-flow

Underlying data: Yahoo Finance.